Atlas Trials

A Phase I Study Comparing Pharmacokinetics and Safety of Bevacizumab

Clinical trial NCT03919448 · COMPLETED

Trial details

NCT number
NCT03919448
Sponsor
Laboratorios Richmond S.A.C.I.F.
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
PharmacokineticsSafety Issues
Start date
2019-04-01
Primary completion
2019-09-11
Enrollment
112

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.